Notably, Ismawati et al. (87) found that proteasome inhibitors reduced early arteriosclerosis in low density lipoprotein receptor (LDLR) mice, this suggests that proteasome inhibitors inhibit the formation of early arteriosclerosis lesions (87). The gene discussed is VLDLR; the disease is arteriosclerosis.